Publications by authors named "Maria Rozman"

Claim this Profile
S
Systemic mastocytosis with an associated myeloid neoplasm: Report from the XVI European Bone Marrow Working Group Course and Workshop, Barcelona 2023.
Roos J Leguit, Maria Rozman, Hans Michael Kvasnicka, Robert P Hasserjian, Leonor Arenillas

Am J Clin Pathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes.
Francesca Guijarro, Sandra Cabezas, Marc Dabad, Alex Bataller, Cristina López, Maria Rozman

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Sandra Castaño-Díez, José Ramón Álamo, Mònica López-Guerra, Marta Gómez-Hernando, Inés Zugasti, Maria Rozman

Oncologist· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.
Jose R Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez, Anna Mensa-Vilaró, M Mónica López-Guerra, Maria Rozman

Br J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, Xavier Calvo, Felicitas Isabel Schulz, Maria Rozman

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.
Stella Charalampopoulou, Elise Chapiro, Ferran Nadeu, Thorsten Zenz, Sílvia Beà, Maria Rozman

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti, Maria Rozman

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
Francesca Guijarro, Sandra Castaño-Díez, Carlos Jiménez-Vicente, Marta Garrote, José Ramón Álamo, Maria Rozman

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Sandra Castaño-Díez, Helena Pomares, Daniel Esteban, Francesca Guijarro, Carlos Jiménez-Vicente, María Rozman

Br J Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel fusion gene in a myeloid/lymphoid neoplasm with rearrangement sensitive to specific inhibition.
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro, Maria Rozman

Leuk Lymphoma· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.
Anna Carbo-Meix, Francesca Guijarro, Luojun Wang, Marta Grau, Romina Royo, Maria Rozman

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrequent Presentations of Chronic -Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
Sandra Castaño-Díez, Francesca Guijarro, Mònica López-Guerra, Amanda Isabel Pérez-Valencia, Marta Gómez-Núñez, María Rozman

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
Leonie Saft, Hans M Kvasnicka, Ludmila Boudova, Umberto Gianelli, Stefano Lazzi, Maria Rozman

Histopathology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about mosaicism.
Jose Manuel Mascaro, Ignasi Rodriguez-Pinto, Gabriela Poza, Anna Mensa-Vilaro, Julian Fernandez-Martin, Maria Rozman

Ann Rheum Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing.
Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Gonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison, José Carlos Martínez-Ávila, Juan Carlos Hernández-Boluda, María Rozman

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Consensus Classification of myelodysplastic syndromes and related entities.
Robert P Hasserjian, Attilio Orazi, Alberto Orfao, Maria Rozman, Sa A Wang

Virchows Arch· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Maria Rozman

Blood· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.
Ferran Nadeu, Romina Royo, Ramon Massoni-Badosa, Heribert Playa-Albinyana, Beatriz Garcia-Torre, Maria Rozman

Nat Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
Sandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, María Rozman

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Valentín Ortiz-Maldonado, Anna Alonso-Saladrigues, Marta Español-Rego, Nuria Martínez-Cibrián, Anna Faura, María Rozman

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Maria Rozman

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Gabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, Eva Gine, Dolors Costa, María Rozman

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.
David F Moreno, Arturo Pereira, Natalia Tovar, María Teresa Cibeira, Laura Magnano, María Rozman

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?
Laura Magnano, Alba Navarro, Mónica López-Guerra, Guillem Clot, Sílvia Beà, María Rozman

Haematologica· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis